Global Latent Tuberculosis Infection Ltbi Testing Market Scope And Analysis

  • Report Code : TIPRE00014239
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Latent TB Detection Market Scope and Analysis Report by 2031

Buy Now


Latent TB Detection Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1.23 Billion
Market Size by 2031 US$ 2.00 Billion
Global CAGR (2023 - 2031) 5.8%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Test
  • Tuberculin Skin Test
  • Interferon Gamma Released Assay
By End User
  • Hospitals
  • Diagnostic Centers
  • Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • QIAGEN
  • BioMeriux S A
  • F Hoffmann La Roche Ltd
  • BD
  • ARKRAY Inc
  • Abbott
  • Serum Institute of India Pvt Ltd
  • Oxford Immunotec Ltd
  • Lionex GmbH
  • Latent TB Detection Market News and Recent Developments

    The latent TB detection market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for latent TB detection:

    • Serum Institute of India (SII) and Mylab Discovery Solutions launched a point-of-care skin test for detecting latent tuberculosis infections (LTBI) at a cost the companies claimed to be 50-70 percent lower than comparable tests available. Through several interventions, this partnership works on tuberculosis diagnosis, treatment, and prevention. (Source: Serum Institute of India (SII)/Press Release, October 2023)
    • Mylab launches kit for detecting TB, multidrug resistance variant in a single test. The kit has been named PathoDetect MTB RIF and INH drug resistance kit. This RT-PCR-based kit for accurate detection will be used with Mylab Compact device systems, which will allow automated testing of multiple samples within two hours. (Source: Reveal Lasers, Press Release, October 2023)

    Latent TB Detection Market Report Coverage and Deliverables

    The “Latent TB Detection Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles